The Preuss Foundation, Inc.

THE PREUSS FOUNDATION 
INTERLEUKIN-2/LAK CELL TREATMENT
OF BRAIN TUMORS SEMINAR I.
June 10, 1987
Dallas, Texas

Gale A. Granger, Ph.D.
UNIVERSITY OF CALIFORNIA, IRVINE
Irvine, California

Elizabeth A. Grimm, Ph.D.
UNIVERSITY OF TEXAS SYSTEM CANCER CENTER
Houston, Texas

Marylou Ingram, M.D.
HUNTINGTON MEDICAL RESEARCH INSTITUTE
Pasadena, California

Steven Jacobs, M.D., Ph.D.
ALBERT EINSTEIN COLLEGE OF MEDICINE
Bronx, New York

Mr. Brent Jorgeson
HEALTHCARE INTERNATIONAL
Austin, Texas

Paul L. Kornblith, M.D.
ALBERT EINSTEIN COLLEGE OF MEDICINE
Bronx, New York

Carol A. Kruse, Ph.D.
UNIVERSITY OF COLORADO
Denver, Colorado

Maria Kuppner, Ph.D.
UNIVERSITY HOSPITAL, CHUV
Lausanne, Switzerland

Kevin O. Lillehei, M.D.
UNIVERSITY OF COLORADO HEATH SCIENCE CENTER
Denver, Colorado

Stephen Mahaley, M.D., Ph.D.
UNIVERSITY OF ALABAMA, BIRMINGHAM
Birmingham, Alabama

Randall E. Merchant, Ph.D.
VIRGINIA COMMONWEALTH UNIVERSITY
Richmond, Virginia

Richard P. Moser, M.D.
M.D. ANDERSON HOSPITAL AND TUMOR INSTITUTE
Houston, Texas

Robert G. Peterson, M.D.
CHILDREN'S HOSPITAL
Boston, Massachusetts

Mark Rosenblum, M.D.
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
San Francisco, California

Harold F. Young, M.D.
VIRGINIA COMMONWEALTH UNIVERSITY
Richmond, Virginia